Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 4/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | PAM | P19021 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | PRKCA | P17252 | 1/20 | 0.46 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.46 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.46 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4849680 | 1.00 | DGKA (0.55) | DGKALMNAMAPTPAMALDH1A1 | |
| SCHEMBL20394158 | 1.00 | DGKA (0.55) | DGKALMNAMAPTPAMALDH1A1 | |
| SCHEMBL1761020 | 1.00 | DGKA (0.55) | DGKALMNAMAPTPAMALDH1A1 | |
| SCHEMBL3075652 | 1.00 | DGKA (0.55) | DGKALMNAMAPTPAMALDH1A1 | |
| SCHEMBL20394156 | 1.00 | DGKA (0.55) | DGKALMNAMAPTPAMALDH1A1 | |
| SCHEMBL21409708 | 1.00 | DGKA (0.55) | DGKALMNAMAPTPAMALDH1A1 | |
| SCHEMBL20394142 | 1.00 | DGKA (0.55) | DGKALMNAMAPTPAMALDH1A1 | |
| SCHEMBL932347 | 1.00 | DGKA (0.55) | DGKALMNAMAPTPAMALDH1A1 | |
| SCHEMBL20394140 | 1.00 | DGKA (0.55) | DGKALMNAMAPTPAMALDH1A1 | |
| SCHEMBL20394164 | 1.00 | DGKA (0.55) | DGKALMNAMAPTPAMALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260021219-A1 | METHODS AND ABSORBENT ARTICLES FOR INHIBITING FECAL PROTEASE ACTIVITY | KIMBERLY CLARK CO (US) | 2026-01-22 | — | — | US | disclosed |
| WO-2024073721-A1 | METHODS AND ABSORBENT ARTICLES FOR INHIBITING FECAL PROTEASE ACTIVITY | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2024-04-04 | — | — | WO | disclosed |
| US-20230265268-A1 | THERMOPLASTIC ELASTOMER COMPOSITION | POLYMAX THERMOPLASTIC ELASTOMERS, LLC | 2023-08-24 | — | — | US | disclosed |
| EP-2701670-B1 | CLEAR WET SUN-CARE SPRAYS AND GELS | ISP INVESTMENTS LLC (US) | 2021-10-20 | — | — | EP | disclosed |
| EP-2134786-B1 | DISPERSION, GEL AND EMULSIFICATION SYSTEM | CRODA SINGAPORE PTE LTD (SG) | 2019-07-31 | — | — | EP | disclosed |
| US-10314774-B2 | Clear wet sprays and gels | ISP INVESTMENT LLC (US) | 2019-06-11 | — | — | US | disclosed |
| EP-2904046-B1 | THERMOPLASTIC ELASTOMER COMPOSITIONS HAVING BIORENEWABLE CONTENT | TEKNOR APEX CO (US) | 2018-11-21 | — | — | EP | disclosed |
| US-10125255-B2 | Thermoplastic elastomer compositions having biorenewable content | TEKNOR APEX COMPANY (US) | 2018-11-13 | — | — | US | disclosed |
| EP-2904045-B1 | THERMOPLASTIC ELASTOMER COMPOSITIONS HAVING BIORENEWABLE CONTENT | TEKNOR APEX CO (US) | 2018-09-19 | — | — | EP | disclosed |
| US-20180140610-A1 | OPIPRAMOL PATCH | NEURODERM, LTD. (IL) | 2018-05-24 | — | — | US | disclosed |
| WO-2002007707-A2 | LINKAGE OF AGENTS USING MICROPARTICLES | PERICOR SCIENCE, INC. (US) | 2002-01-31 | — | — | WO | disclosed |
| WO-2002000797-A1 | PARTICULATE METAL OXIDE | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 2002-01-03 | — | — | WO | disclosed |
| EP-1141111-A1 | GEL COMPOSITIONS | Penreco (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2001007009-A1 | LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE | PERICOR SCIENCE, INC. (US) | 2001-02-01 | — | — | WO | disclosed |
| WO-2001006829-A2 | LINKAGE OF AGENTS TO TISSUE | PERICOR SCIENCE, INC. (US) | 2001-02-01 | — | — | WO | disclosed |
| EP-1011609-A4 | COMPOSITIONS FOR COSMETIC APPLICATIONS | MEDLOGIC GLOBAL CORP (US) | 2000-08-16 | — | — | EP | disclosed |
| EP-1011609-A1 | COMPOSITIONS FOR COSMETIC APPLICATIONS | MedLogic Global Corporation (US) | 2000-06-28 | — | — | EP | disclosed |
| WO-2000026285-A1 | GEL COMPOSITIONS | PENRECO (US) | 2000-05-11 | — | — | WO | disclosed |
| WO-1998048768-A9 | COMPOSITIONS FOR COSMETIC APPLICATIONS | MEDLOGIC GLOBAL CORP (US) | 1999-03-25 | — | — | WO | disclosed |
| WO-1998050005-A1 | COMPOSITIONS FOR COSMETIC APPLICATIONS | MEDLOGIC GLOBAL CORPORATION (US) | 1998-11-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260021219-A1 | METHODS AND ABSORBENT ARTICLES FOR INHIBITING FECAL PROTEASE ACTIVITY | CUTA, CTRL, PEPD | DGKA 2481/4885LMNA 1595/4885MAPT 1996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.